Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome.

Lunn, Michael P; Carr, Aisling C; Keddie, Stephen; Pakpoor, Julia; Pipis, Menelaos; Willison, Hugh J

Lunn, Michael P; Carr, Aisling C; Keddie, Stephen; Pakpoor, Julia; Pipis, Menelaos; Willison, Hugh J.

Lunn MP; Department of Neuromuscular Diseases, University College London, London, UK.
Carr AC; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
Keddie S; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
Pakpoor J; Department of Neuromuscular Diseases, University College London, London, UK.
Pipis M; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
Willison HJ; Oxford School of Public Health, Oxford, UK.

Brain ; 144(5): e47, 2021 06 22.

Article in English | MEDLINE | ID: covidwho-1169658

Subject(s)

COVID-19; Guillain-Barre Syndrome; Humans; Longitudinal Studies; Molecular Mimicry; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Brain Year: 2021 Document Type: Article Affiliation country: Brain

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google